TNFSF11 and osteoporosis: In 2009, Lee et al.26employed a mouse model to illustrate the inhibitory effect of alendronate on RANKL‐mediated differentiation of bone macrophages into osteoclasts in a dose‐dependent manner, providing insight into the therapeutic mechanism of alendronate in treating osteoporosis.